Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-01-27 @ 1:43 AM
Study NCT ID:
NCT00951457
Status:
COMPLETED
Last Update Posted:
2022-03-03
First Post:
2009-08-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Organization: